Impact of Motile Ciliopathies on Human Development and Clinical Consequences in the Newborn

Rachael M Hyland1, Steven L Brody2

  • 1Department of Pediatrics, Division of Newborn Medicine, Washington University in Saint Louis School of Medicine, Saint Louis, MO 63110,USA.

Cells
|January 11, 2022
PubMed

Insights

Motile cilia are crucial for human development, guiding embryonic left-right axis determination and neonatal functions like airway clearance. Understanding primary ciliary dyskinesia (PCD) is vital for diagnosing neonatal respiratory distress and other ciliopathies.

Area of Science:

  • Developmental Biology
  • Cell Biology
  • Genetics

Background:

  • Motile cilia are essential organelles directing fluid flow in human development and neonatal physiology.
  • Primary ciliary dyskinesia (PCD) is a genetic disorder caused by over 60 mutations, impacting motile cilia function.
  • PCD has a distinct neonatal presentation, often including respiratory distress, laterality defects, and rarely, brain ventricle enlargement.

Purpose of the Study:

  • To review the current understanding of motile cilia's role in human development.
  • To discuss the clinical considerations for assessing newborns with suspected motile ciliopathies.
  • To highlight the pathophysiology and developmental impact of motile cilia dysregulation.

Main Methods:

  • Literature review of studies on motile cilia and primary ciliary dyskinesia.
  • Analysis of the developmental functions of motile cilia.
  • Examination of clinical presentations and diagnostic considerations for neonatal ciliopathies.

Main Results:

  • Motile cilia are critical for establishing the embryonic left-right axis.
  • In neonates, motile cilia are vital for airway clearance and cerebrospinal fluid regulation.
  • The majority of PCD patients exhibit neonatal respiratory distress, with laterality defects also common.

Conclusions:

  • Motile cilia play indispensable roles throughout human development and neonatal life.
  • Primary ciliary dyskinesia presents unique neonatal challenges requiring early recognition and assessment.
  • Further research is needed to fully elucidate the developmental functions and pathophysiology of motile cilia and their disorders.

Related Concept Videos

Microtubules in Signaling01:22

Microtubules in Signaling

The primary cilium, made up of microtubules, acts as antennae on the cell surfaces for relaying external stimuli into the cells. These fine hair-like structures are present, generally one per cell. These are non-motile cilia in a 9+0 microtubules arrangement, where the central pair of microtubules are absent. The primary cilia arise from the basal body embedded in the cell membrane. Intraflagellar transport (IFT) carries requisite proteins from the cytoplasm to the cilium because the primary...
1.8K
Mechanism of Ciliary Motion01:05

Mechanism of Ciliary Motion

The ciliary structures were first seen in 1647 by Antonie Leeuwenhoek while observing the protozoans. In lower organisms, these appendages are responsible for cell movement, while in higher organisms, these appendages help in the movement of the extracellular fluids within the body cavities.
The cilia are made up of microtubules in a 9+2 arrangement, with nine microtubule doublet ring bundles, surrounding a pair of central singlet microtubule bundles. The doublet microtubule bundles are...
4.0K
Cystic Fibrosis: Pathogenesis01:23

Cystic Fibrosis: Pathogenesis

Cystic fibrosis (CF), an autosomal recessive disorder, significantly affects the function of exocrine glands. This genetically inherited disease is characterized by the production of thick and sticky mucus, which can severely affect various organs and systems in the body.
CF is primarily caused by a genetic mutation in a chromosome 7 gene coding for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. The most common gene mutation leading to CF is the ΔF508 mutation,...
390
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses...
17